Growth hormone cotreatment for low-prognosis patients according to the POSEIDON criteria
X Liu, J Xu, L Bi, P Liu, X Jiao - Frontiers in Endocrinology, 2021 - frontiersin.org
Background Poor ovarian response (POR) remains one of the most challenging conditions
in assisted reproduction technology. Previous studies seemed to indicate that growth …
in assisted reproduction technology. Previous studies seemed to indicate that growth …
The effect of growth hormone adjuvant therapy on assisted reproductive technologies outcomes in patients with diminished ovarian reserve or poor ovarian response
Low response of patients with diminished ovarian reserve to exogenous gonadotropins in
controlled ovarian stimulation (COS) protocols is one of the important problems of …
controlled ovarian stimulation (COS) protocols is one of the important problems of …
The Effect of Growth Hormone on the Clinical Outcomes of Poor Ovarian Reserve Patients Undergoing in vitro Fertilization/Intracytoplasmic Sperm Injection Treatment …
M Cai, L Gao, XY Liang, C Fang, Y Wu… - Frontiers in …, 2019 - frontiersin.org
The aim of this retrospective analysis is to explore whether growth hormone (GH)
pretreatment is beneficial for patients with poor ovarian reserve undertaking in vitro …
pretreatment is beneficial for patients with poor ovarian reserve undertaking in vitro …
Six‐week pretreatment with growth hormone improves clinical outcomes of poor ovarian responders undergoing in vitro fertilization treatment: A self‐controlled …
MH Cai, XY Liang, YQ Wu, R Huang… - Journal of Obstetrics …, 2019 - Wiley Online Library
Aim The purpose was to explore whether the 6 weeks of growth hormone (GH) pretreatment
could increase the live birth rate of poor ovarian responders (POR). Methods This self …
could increase the live birth rate of poor ovarian responders (POR). Methods This self …
[HTML][HTML] Efficacy of growth hormone supplementation with gonadotrophins in vitro fertilization for poor ovarian responders: an updated meta-analysis
X Yu, J Ruan, LP He, W Hu, Q Xu, J Tang… - … journal of clinical and …, 2015 - ncbi.nlm.nih.gov
Growth hormone (GH) is involved in the regulation of male and female infertility. Several
clinical studies reveal that adjuvant GH treatment has a possible role in vitro fertilization …
clinical studies reveal that adjuvant GH treatment has a possible role in vitro fertilization …
[HTML][HTML] Comparison of different ovarian hyperstimulation protocols efficacy in poor ovarian responders according to the Bologna criteria
L Hu, Z Bu, Y Guo, Y Su, J Zhai… - International journal of …, 2014 - ncbi.nlm.nih.gov
Many protocols have been proposed to improve IVF outcomes for poor ovarian responders.
The aim of this study was to explore the relationship between age, ovarian hyperstimulation …
The aim of this study was to explore the relationship between age, ovarian hyperstimulation …
The effect of growth hormone supplementation in poor ovarian responders undergoing IVF or ICSI: a meta-analysis of randomized controlled trials
P Yang, R Wu, H Zhang - Reproductive Biology and Endocrinology, 2020 - Springer
Purpose The aim of this meta-analysis was to evaluate the effect of growth hormone (GH)
supplementation in poor responders undergoing in vitro fertilization (IVF) or intracytoplasmic …
supplementation in poor responders undergoing in vitro fertilization (IVF) or intracytoplasmic …
Predictive Factors for Live Birth in Fresh In Vitro Fertilization/Intracytoplasmic Sperm Injection Treatment in Poor Ovarian Reserve Patients Classified by the …
F Li, T Ye, H Kong, J Li, L Hu, HX Jin… - Frontiers in …, 2021 - frontiersin.org
The mechanisms underlying poor ovarian response (POR) in assisted reproductive
technology remain unclear, there is no consensus on the management of poor responders …
technology remain unclear, there is no consensus on the management of poor responders …
The influence of different growth hormone addition protocols to poor ovarian responders on clinical outcomes in controlled ovary stimulation cycles: a systematic …
XL Li, L Wang, F Lv, XM Huang, LP Wang, Y Pan… - Medicine, 2017 - journals.lww.com
Background: Growth hormone (GH) is used as an adjuvant therapy in in vitro fertilization and
embryo transfer (IVF-ET) for poor ovarian responders, but findings for its effects on outcomes …
embryo transfer (IVF-ET) for poor ovarian responders, but findings for its effects on outcomes …
Defining low prognosis patients undergoing assisted reproductive technology: POSEIDON criteria—the why
Women with impaired ovarian reserve or poor ovarian response (POR) to exogenous
gonadotropin stimulation present a challenge for reproductive specialists. The primary …
gonadotropin stimulation present a challenge for reproductive specialists. The primary …